Na Jin

634 total citations
38 papers, 398 citations indexed

About

Na Jin is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Na Jin has authored 38 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Psychiatry and Mental health, 8 papers in Pediatrics, Perinatology and Child Health and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Na Jin's work include Schizophrenia research and treatment (16 papers), Bipolar Disorder and Treatment (8 papers) and Pharmaceutical studies and practices (6 papers). Na Jin is often cited by papers focused on Schizophrenia research and treatment (16 papers), Bipolar Disorder and Treatment (8 papers) and Pharmaceutical studies and practices (6 papers). Na Jin collaborates with scholars based in China, United States and Denmark. Na Jin's co-authors include Robert D. McQuade, William H. Carson, Ross A. Baker, Raymond Sanchez, B. Johnson, Timothy Peters-Strickland, Anna Eramo, John M. Kane, W. Wolfgang Fleischhacker and Pamela Perry and has published in prestigious journals such as SHILAP Revista de lepidopterología, The British Journal of Psychiatry and Journal of Affective Disorders.

In The Last Decade

Na Jin

36 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Na Jin China	10	273	79	64	55	50	38	398
Jan Bogers Netherlands	13	294 1.1×	23 0.3×	79 1.2×	44 0.8×	65 1.3×	35	468
Anja Glockmann Germany	17	158 0.6×	39 0.5×	62 1.0×	41 0.7×	34 0.7×	31	646
Maud Beillat France	10	204 0.7×	36 0.5×	45 0.7×	67 1.2×	57 1.1×	28	492
David Healy Ireland	7	59 0.2×	38 0.5×	99 1.5×	28 0.5×	46 0.9×	30	348
Katrin Ruth Sigurdardottir Norway	11	186 0.7×	83 1.1×	82 1.3×	10 0.2×	88 1.8×	17	427
Louise Glassner Cohen United States	13	256 0.9×	76 1.0×	115 1.8×	72 1.3×	3 0.1×	22	487
Kyoko Higashi Japan	7	349 1.3×	39 0.5×	145 2.3×	24 0.4×	72 1.4×	10	535
Jonathan Favre France	7	102 0.4×	46 0.6×	29 0.5×	18 0.3×	7 0.1×	15	266
Miek C. Jong Netherlands	14	43 0.2×	76 1.0×	38 0.6×	13 0.2×	13 0.3×	32	390
Talia Puzantian United States	9	64 0.2×	32 0.4×	36 0.6×	35 0.6×	11 0.2×	15	301

Countries citing papers authored by Na Jin

Since Specialization

Citations

This map shows the geographic impact of Na Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Jin more than expected).

Fields of papers citing papers by Na Jin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Na Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Jin. The network helps show where Na Jin may publish in the future.

Co-authorship network of co-authors of Na Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Na Jin. A scholar is included among the top collaborators of Na Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Na Jin. Na Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wilens, Timothy E., et al.. (2025). Efficacy and Safety of Centanafadine for ADHD Treatment in Children: A Randomized Clinical Trial. 1(3). 1–11. 1 indexed citations

Such, Pedro, et al.. (2024). Use of an injection of aripiprazole given once every 2 months (Abilify Asimtufii^®) in people with bipolar I disorder: a Plain Language Summary of Publication. SHILAP Revista de lepidopterología. 14. 1957196142–1957196142.

Lu, Wenting, Xiaochuan Zhao, Na Li, et al.. (2024). Suicidal ideation in medical students of Hebei province: prevalence and associated factors. Frontiers in Psychiatry. 15. 1398668–1398668. 2 indexed citations

Zhang, Xiaoshu, Lei Meng, Donghua Li, et al.. (2023). Immediate and long-term changes in infectious diseases in China at the “First-level-response”, “Normalized-control” and “Dynamic-COVID-zero” stages from 2020 to 2022: a multistage interrupted-time-series-analysis. BMC Public Health. 23(1). 1381–1381. 6 indexed citations

Such, Pedro, et al.. (2023). A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder. CNS Drugs. 37(4). 337–350. 17 indexed citations

Li, Donghua, Xiaoshu Zhang, Na Jin, et al.. (2022). A comparison of clinical manifestations of Japanese encephalitis between children and adults in Gansu Province, Northwest China (2005–2020). Acta Tropica. 231. 106449–106449. 7 indexed citations

Meng, Lei, Donghua Li, Na Jin, et al.. (2022). Effect of different vaccine strategies for the control of Japanese encephalitis in mainland China from 1961 to 2020: A quantitative analysis. Vaccine. 40(43). 6243–6254. 8 indexed citations

Meng, Lei, Donghua Li, Na Jin, et al.. (2022). Impact of the expanded program on immunization on the incidence of Japanese encephalitis in different regions of Mainland China: An interrupt time series analysis. Acta Tropica. 233. 106575–106575. 8 indexed citations

Wang, Xuxia, Li Su, Shougang Sun, et al.. (2021). Long-Term Neurological Sequelae and Disease Burden of Japanese Encephalitis in Gansu Province, China. Annals of Global Health. 87(1). 103–103. 10 indexed citations

10.

Li, Xingming, Chunhua Jin, Jianhong Wang, et al.. (2021). Association Between Serum Vitamin A Levels and Recurrent Respiratory Tract Infections in Children. Frontiers in Pediatrics. 9. 756217–756217. 6 indexed citations

11.

Zhang, Shuang, Xueqian Wang, Fafeng Cheng, et al.. (2020). Network Pharmacology‐Based Approach to Revealing Biological Mechanisms of Qingkailing Injection against IschemicStroke: Focusing on Blood‐Brain Barrier. Evidence-based Complementary and Alternative Medicine. 2020(1). 2914579–2914579. 7 indexed citations

12.

Calabrese, Joseph R., Na Jin, B. Johnson, et al.. (2018). Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study. International Journal of Bipolar Disorders. 6(1). 14–14. 10 indexed citations

13.

Peters-Strickland, Timothy, Anna‐Greta Nylander, Ross A. Baker, et al.. (2017). Aripiprazole Once-Monthly 400 mg: Comparison of Pharmacokinetics, Tolerability, and Safety of Deltoid Versus Gluteal Administration. The International Journal of Neuropsychopharmacology. 20(4). 295–304. 28 indexed citations

14.

Calabrese, Joseph R., Raymond Sanchez, Na Jin, et al.. (2017). Symptoms and functioning with aripiprazole once-monthly injection as maintenance treatment for bipolar I disorder. Journal of Affective Disorders. 227. 649–656. 21 indexed citations

15.

Zhang, Xiaoshu, Hong Fu, Jing An, et al.. (2014). [Study on the risk factors of measles among the 8-month-olds and children≥15 years of age in Gansu province].. PubMed. 35(10). 1095–8. 2 indexed citations

16.

Fleischhacker, W. Wolfgang, Raymond Sanchez, Pamela Perry, et al.. (2014). Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study. The British Journal of Psychiatry. 205(2). 135–144. 120 indexed citations

17.

Fleischhacker, W. Wolfgang, Pamela Perry, Raymond Sanchez, et al.. (2013). Functional Outcomes with Aripiprazole Once-Monthly in Two Double-Blind, Placebo- and Active-Controlled Studies (Aspire US 246 and Aspire EU 247) for the Treatment of Schizophrenia. Value in Health. 16(7). A550–A550. 1 indexed citations

18.

Findling, Robert L., Christoph U. Correll, Margaretta Nyilas, et al.. (2013). Aripiprazole for the treatment of pediatric bipolar I disorder: a 30‐week, randomized, placebo‐controlled study. Bipolar Disorders. 15(2). 138–149. 48 indexed citations

19.

Zhu, K. J., et al.. (2009). Complete atrioventricular block associated with dapsone therapy: a rare complication of dapsone-induced hypersensitivity syndrome. Journal of Clinical Pharmacy and Therapeutics. 34(4). 489–492. 22 indexed citations

20.

Sarapa, Nenad, Steven R. Cox, Steven F. Francom, et al.. (2003). Valdecoxib, a COX‐2‐Specific Inhibitor, Does Not Affect Cardiac Repolarization. The Journal of Clinical Pharmacology. 43(9). 974–982. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact